University of Vermont
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1791-01-01
- Employees
- 51
- Market Cap
- -
- Website
- http://www.uvm.edu
The Effect of Administration on N-Acetylcysteine on Serum Creatinine Levels in Patients With Chronic Kidney Disease
- Conditions
- Chronic Kidney Disease
- First Posted Date
- 2007-07-10
- Last Posted Date
- 2008-02-18
- Lead Sponsor
- University of Vermont
- Registration Number
- NCT00498342
- Locations
- 🇺🇸
University of Vermont /Fletcher Allen Health Care, Inc., Burlington, Vermont, United States
Safety Study of Nifurtimox for Relapsed or Refractory Neuroblastoma
- Conditions
- Neuroblastoma
- First Posted Date
- 2007-06-14
- Last Posted Date
- 2009-10-23
- Lead Sponsor
- University of Vermont
- Target Recruit Count
- 20
- Registration Number
- NCT00486564
- Locations
- 🇺🇸
St. Louis University/Cardinal Glennon Childrens Medical Center, St. Louis, Missouri, United States
🇺🇸University of Vermont/Vermont Children's Hospital, Burlington, Vermont, United States
Campylobacter Jejuni Challenge Model Development: Dose Ranging Study
- Conditions
- Campylobacter Infections
- First Posted Date
- 2007-02-13
- Last Posted Date
- 2008-06-05
- Lead Sponsor
- University of Vermont
- Target Recruit Count
- 50
- Registration Number
- NCT00434798
- Locations
- 🇺🇸
University of Vermont College of Medicine, Burlington, Vermont, United States
Nasally Delivered Pulmozyme for Sinusitis in Cystic Fibrosis
- Conditions
- SinusitisCystic Fibrosis
- Interventions
- Drug: Pulmozyme (dornase alfa)Drug: Placebo
- First Posted Date
- 2006-12-27
- Last Posted Date
- 2014-11-14
- Lead Sponsor
- University of Vermont
- Target Recruit Count
- 16
- Registration Number
- NCT00416182
- Locations
- 🇺🇸
Fletcher Allen Health Care, Burlington, Vermont, United States
Evaluating the Relationship Between Blood Clotting Disorders, Inflammation, and Obesity in Individuals With Venous Disorders and Post-Thrombotic Syndrome
- Conditions
- Venous ThrombosisVenous Insufficiency
- First Posted Date
- 2006-11-02
- Last Posted Date
- 2012-01-31
- Lead Sponsor
- University of Vermont
- Target Recruit Count
- 2211
- Registration Number
- NCT00395265
- Locations
- 🇺🇸
University of Vermont College of Medicine, Burlington, Vermont, United States
Anxiety Sensitivity Program for Smoking Cessation
- Conditions
- Smoking Cessation
- Interventions
- Behavioral: Anxiety Sensitivity Program for Smoking Cessation
- First Posted Date
- 2006-10-12
- Last Posted Date
- 2010-10-22
- Lead Sponsor
- University of Vermont
- Target Recruit Count
- 80
- Registration Number
- NCT00387049
- Locations
- 🇺🇸
University of Vermont, Burlington, Vermont, United States
Partial Breast Radiation to the Lumpectomy Cavity With IMRT in Elderly Women
- Conditions
- Stage I Breast Cancer
- First Posted Date
- 2006-06-15
- Last Posted Date
- 2006-06-15
- Lead Sponsor
- University of Vermont
- Target Recruit Count
- 75
- Registration Number
- NCT00337064
- Locations
- 🇺🇸
Fletcher Allen Health Care, Radiation Oncology, Burlington, Vermont, United States
Gradual vs. Abrupt Cessation Treatment for Smoking
- Conditions
- Smoking Cessation
- Interventions
- Behavioral: Abrupt Phone CounselingBehavioral: Minimal Abrupt Phone CounselingBehavioral: Reduction Phone CounselingDrug: Pre-Quit Nicotine LozengesDrug: Post-Quit Nicotine Lozenges
- First Posted Date
- 2006-02-28
- Last Posted Date
- 2013-09-20
- Lead Sponsor
- University of Vermont
- Target Recruit Count
- 750
- Registration Number
- NCT00297492
- Locations
- 🇺🇸
University of Vermont Human Behavioral Pharmacology Lab, Burlington, Vermont, United States
Tinzaparin in Treating Patients With Metastatic Kidney Cancer That Cannot Be Removed By Surgery
- Conditions
- Kidney Cancer
- First Posted Date
- 2006-02-17
- Last Posted Date
- 2013-11-06
- Lead Sponsor
- University of Vermont
- Target Recruit Count
- 35
- Registration Number
- NCT00293501
- Locations
- 🇺🇸
Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States
🇺🇸University of Chicago Cancer Research Center, Chicago, Illinois, United States
🇺🇸Vermont Cancer Center at University of Vermont, Burlington, Vermont, United States
A Telephone Feedback System for Prevention of Chronic Pain Relapse
- Conditions
- Chronic Pain and Relapse Prevention
- Interventions
- Behavioral: Chronic pain therapeutic interactive voice response (TIVR) system
- First Posted Date
- 2005-12-19
- Last Posted Date
- 2013-02-18
- Lead Sponsor
- University of Vermont
- Target Recruit Count
- 158
- Registration Number
- NCT00266773
- Locations
- 🇺🇸
University of Vermont College of Medicine - MindBody Medicine Clinic, Burlington, Vermont, United States